Ischemic Stroke
Conditions
Brief summary
The current management of ischemic stroke is based on different strategies that may be combined: intravenous thrombolysis in a stroke ICU, intravenous thrombolysis in a telemedicine procedure, endovascular thrombectomy. Given this now rich therapeutic arsenal, it seems necessary to evaluate practices in local care in the field and the impact of these on the prognosis of ischemic stroke victims. The aim of this observational study is to compare these different care practices without interfering with the choice of strategy. A blood sample will also be taken at different times to study the value of growth differentiation factors (GDF) 8, 11 and 15, and Brain-derived Neurotrophic Factor as prognostic biomarkers
Interventions
BIOLOGICALprise de sang
OTHERquality of life questionnaire
Sponsors
Centre Hospitalier Universitaire Dijon
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients with symptomatic ischemic stroke defined according to WHO criteria and treated by intravenous thrombolysis at the stroke ICU at Dijon CHU, intravenous thrombolysis by telemedicine with subsequent transfer to the Dijon stroke ICU, and/or endovascular thrombectomy at Dijon CHU) * Patients aged over 18 years. * Patients who have provided written informed consent to take part in the study.
Exclusion criteria
* Patients who refuse to take part in the study. * Subjects in custody. * Patients (or a person of trust) who cannot be contacted by telephone during the follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of handicap | 6 months |
Secondary
| Measure | Time frame |
|---|---|
| Serum levels of biomarkers of stress | Changes compared with baseline levels at Day 1, Day 3, Day 7 |
Countries
France
Outcome results
None listed